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Abstract: Presently some three hundred post-translational modifications are known to occur in bacteria in vivo. Many of 
these modifications play critical roles in the regulation of proteins and control key biological processes. One of the most 
predominant modifications, N- and O-glycosylations are now known to be present in bacteria (and archaea) although they 
were long believed to be limited to eukaryotes. In a number of human pathogens these glycans have been found attached 
to the surfaces of pilin, flagellin and other surface and secreted proteins where it has been demonstrated that they play a 
role in the virulence of these bacteria. Mass spectrometry characterization of these glycosylation events has been the ena-
bling key technology for these findings. This review will look at the use of mass spectrometry as a key technology for the 
detection and mapping of these modifications within microorganisms, with particular reference to the human pathogens, 
Campylobacter jejuni and Mycobacterium tuberculosis. The overall aim of this review will be to give a basic understand-
ing of the current ‘state-of-the-art’ of the key techniques, principles and technologies, including bioinformatics tools, in-
volved in the analysis of the glycosylation modifications. 
Keywords: Proteomics, mass spectrometry, post-translational modifications, glycosylation, eukaryota, prokaryota  
Campylobacter jejuni, Mycobacterium tuberculosis. 
INTRODUCTION 
 The oligomerization of different classes of biomolecules 
lays the foundation for the construction of a coding system 
for information storage [1]. This is best exemplified by the 
genome, that with the exception of epigenetic changes may 
be considered static, and the proteome, which is considered 
much more complex and dynamic [2].  
 It is only in the last few decades that the functional im-
portance of the carbohydrates as a third class of bio-
molecules involved in information storage has been recog-
nized [3]. The oligomerization of carbohydrates can give rise 
to an almost boundless array of structures. A hexasaccharide 
comprising only four different hexose sugars is capable of 
giving rise to 2.7 billion different and distinct structures [4], 
whilst the number of possible isomers of a hexasaccharide 
comprising a set of six hexose’s is greater than 1.05 x 10
12
 
[5]. In contrast a sequence of six amino acids only generates 
~ 50,000 different structures. Thus carbohydrates have the 
potential to carry information content several orders of mag-
nitude higher in a short sequence than any other bio-
molecule. This vast array of structures in carbohydrates is 
accounted for by several factors: carbohydrates can exist in a 
number of epimeric forms with variations occurring in ano-
meric configuration, ring size, core and branching sequences 
and the linking, branching and reducing terminal attachments 
can also differ [5].  
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 In biological systems these sugar moieties are most 
commonly covalently attached to the polypeptide backbone 
of proteins and are amongst the most abundant co- and post-
translational modifications observed in nature, with as much 
as half of all proteins being predicted to be glycosylated [1, 
6-8].  
 Glycosylation events give rise to the production of a 
large number of glycoproteins. These differ by the amino 
acid to which the sugar is connected as well as the composi-
tion of the attached carbohydrate units. Diversity is also in-
creased when taking into account the position and linkages 
between the sugars and also the monomeric sequences and 
their anomeric forms. Separate populations of glycoproteins 
also exist that have identical amino acid sequences but differ 
only in the compositions of glycans attached to the sites of 
glycosylation, these different ‘glycoforms’ of the same pro-
tein produce a high degree of micro-heterogeneity [1, 2, 7].  
 Due to their prominent positions on the cell surface, gly-
coproteins are often the first cellular components encoun-
tered by pathogens. After cell-pathogen contact, glycopro-
teins are ideally suited to modulate a myriad of signaling 
processes [9]. Almost all of the key components of the im-
mune system are glycoproteins. In fact, all of the immuno-
globulins are glycosylated; here the sugar moieties are re-
sponsible for imparting stability and are also involved in the 
production of specific recognition epitopes that facilitate 
binding to receptors for the initiation of signaling events 
[10].  
 In a number of human pathogens glycans have been 
found attached to the surfaces of pilin, flagellin and other 
surface and secreted proteins where it has been demonstrated 
that they play a role in adhesion, colonization, pathogenicity, 
immune evasion and virulence of these bacteria [11-14]. 
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Given the ubiquitous distribution of these glycoproteins the 
study of the ‘glycome’, i.e.; all the sets of gly-
cans/glycoproteins expressed within a biological system, 
must be an intrinsic part of any research into the understand-
ing of biological processes [15]. 
THE ROLE OF MASS SPECTROMETRY (MS) IN 
GLYCOPROTEOMICS 
 A dizzying array of glycan structures can be expressed in 
an organism at any specific time. Given the physiological 
importance of this co/post-translational process numerous 
research groups have dedicated significant time and effort to 
the analysis and characterization of specific glycan structures 
and the proteins to which these glycans are attached. This 
work has given rise to the fields of ‘glycomics’, which at-
tempts to study the significance and characterize the total N- 
and O-glycosylation expression within a biological system, 
and ‘glycoproteomics’, which is concerned with glycopep-
tide analysis [16].  
 Since the first successful structural analysis of a complex 
naturally occurring glycopeptide, leading to the elucidation 
of the full primary structure of the antifreeze glycoprotein 
from the Antarctic Fish Trematomus borchgrevinki, [17] 
mass spectrometry has been a central and irreplaceable ena-
bling technology in the analysis and elucidation of glycopro-
teins [18].  
 For a number of years characterization of glycan struc-
tures has almost exclusively been the domain of mass spec-
trometry [19] and in conjunction with nuclear magnetic 
resonance (NMR) has been used extensively to define novel 
and unusual glycan structures associated with bacterial pro-
teins [2]. Mass spectrometry as an analytical technique re-
quires that samples to be analyzed are converted into ions in 
the gaseous phase. The mass spectrometer separates these 
ions according to their mass-to-charge ratio (m/z) and re-
cords the relative abundance of each of the ions to obtain a 
mass spectrum [20]. For more detailed information on mass 
spectrometry principles and instrumentation the reader is 
directed to the reviews of Domon & Abersold [21], Abersold 
& Mann [22], Graham et al. [23] , Smith et al. [24, 25] and 
Yates et al. [26, 27]. 
 The development of 'soft ionization' techniques in the 
1980s allowed the ionization of large, polar, and thermally 
labile biomolecules including glycopeptides [28] that did not 
previously lend themselves to such analytical techniques [29, 
30]. The two critical 'soft ionization' technologies are elec-
trospray ionization mass spectrometry (ESI-MS) and matrix-
assisted laser desorption ionization mass spectrometry 
(MALDI- MS).  
Electrospray Ionization (ESI) 
 ESI has become a mainstream method for life science 
research as a result of its high sensitivity and broad applica-
bility. ESI is typically carried out in conjunction with high 
performance liquid chromatography (HPLC) and can be used 
with a nano electrospray configuration [31]. There are two 
models of how ions are generated in ESI, the charged droplet 
model and the ion evaporation model. In the charged droplet 
model, ESI generates charged micro-droplets containing 
analyte ions. The sample of interest is dissolved in a solvent 
and then pumped through a thin capillary or needle that is 
raised to a high potential that may be positive or negative. 
Due to the application of the electric field the solution exits 
the tip of the capillary in the shape of a cone, known as the 
Taylor cone [32]. Charged droplets are sprayed from the 
apex of the cone when the electrostatic repulsion of the 
charged molecules approaches the surface tension of the so-
lution. These small charged droplets travel down a pressure 
and potential gradient towards an orifice in the mass spec-
trometer. As the droplets traverse this path they become 
desolvated and reduced in size, however, their charge re-
mains constant [33]. Electrostatic stress near the surface of 
the droplet increases as the droplet shrinks. When the force 
of electrostatic repulsion between like charges becomes 
equal to the surface tension of the droplet, it undergoes Cou-
lombic fission leading to the production of smaller droplets 
[34]. In the charged residue model these fissions ultimately 
produce droplets small enough to contain only one analyte 
molecule. As the last of the solvent evaporates from the 
droplet the analyte molecule retains some of the charge of 
the droplet to become an ion [35]. In the ion evaporation 
model following Coulombic fissions a droplet does not have 
to be formed containing only one analyte ion. Instead solvent 
evaporation increases the surface charge density at the drop-
let surface. When the droplet becomes small enough, the 
small radius of curvature and high charge density are strong 
enough to overcome the solvation forces holding the ion to 
the droplet and it is lifted from the droplet surface into the 
ambient gas [36]. In the first model the solvent leaves the ion 
and in the second the ion leaves the solvent [37]. The gas 
phase ions then enter the mass spectrometer and are detected 
as a series of multiply charged ions (e.g. [M+nH]
n+
). ESI as 
an ionization process is relatively gentle, resulting in little or 
no fragmentation of the glycans or glycoproteins/gly-
copeptides being studied [28]. The absence of matrix adducts 
also leads to cleaner mass spectra when compared to MALDI 
[38]. However, native glycans are not ionized well by this 
process and therefore information on them can be lost [39]. 
The sample being investigated must also be free of salts and 
other contaminants, so some form of sample clean up is usu-
ally required prior to ESI [38].  
Matrix-Assisted Laser Desorption-Ionization (MALDI) 
 Matrix-assisted laser desorption-ionization (MALDI) is a 
method that uses a laser to desorb intact molecular ions of 
proteins and peptides that are co-crystallized in a photoactive 
matrix solution [40, 41]. Unlike ESI, generally only singly 
charged ions are observed for MALDI. In MALDI, the ana-
lyte of interest is co-crystallized with an excess of matrix, 
that is used as a diluent preventing the analyte from forming 
large aggregates that would otherwise be too large to desorb 
[42, 43]. The matrix also absorbs UV light from a laser thus 
facilitating analyte desorption and ionization [42]. There are 
a number of different matrices that may be used in MALDI-
MS. Typically, matrices for the analysis of glycans are 2,5-
dihydroxybenzoic acid and its derivatives [44]. Analyte and 
matrix are both spotted onto a metal target plate, which is 
then inserted into a high vacuum source region within the 
mass spectrometer [43]. The target plate is subjected to laser 
bombardment and analyte molecules are vaporized along 
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with the matrix molecules. The process of desorption and 
ionization in MALDI is not fully understood with several 
influencing factors such as, laser wavelength, pulse width 
and chemical properties of the matrix and analyte [45]. Dur-
ing laser irradiation a gas jet of matrix neutrals and surround-
ing analyte molecules is formed. The matrix molecules are 
strongly excited at this stage and analyte molecules are 
thought to be ionized as a result of multi-step interactions 
with the matrix resulting in proton transfer giving both pro-
tonated and deprotonated analyte ions [42, 43]. One of the 
advantages of this technique is that you can obtain spectra 
from unmodified glycans [39, 44, 46] and the technique also 
has a high tolerance for salts and other contaminants [38]. 
MALDI is, however, a harsher ionization process than ESI 
resulting in the fragmentation of acidic glycans particularly 
sialic acid (9) residues [39]. 
TANDEM MS 
 The use of mass spectrometry in glycoproteomics is pri-
marily advantageous because it has the ability to produce 
mass spectra, which tend to be unique for a particular glyco-
peptide/glycoprotein and thus can be used in the characteri-
zation of the peptide/protein and the mapping of any modifi-
cations [18]. The investigation of glycoproteins may be car-
ried out using one of two approaches either ‘top down’ or 
‘bottom up’ [47]. The goal of the top down methodology is 
to identify intact glycoproteins using mass spectrometry, 
without the need for prior proteolytic digestion of the sam-
ple. Initially proteins are introduced into the mass spec-
trometer in the gas phase and are then fragmented [48-50]. 
This methodology has proved to be extremely useful in bac-
terial glycoproteomics in the elucidation of novel glycan 
structures such as those attached to the pilin in Neisseria sp. 
[51, 52] and Mycobacterium tuberculosis [53]. This method-
ology is not as widely used as the bottom up approach as it 
typically requires a high resolution mass spectrometer such 
as FT-ICR [47] or MALDI/TOF-TOF [50]. However, this 
technique is increasingly being used in conjunction with bot-
tom up methodologies, to gain wider structural information 
for the identification of bacterial glycoprotein’s and glycan 
structures [54]. The more widely used approach when inves-
tigating glycopeptides is the bottom up strategy. This ap-
proach refers to any methodology that identifies proteins 
from the analysis of peptides derived from the proteolytic 
digestions of those proteins [55].  
 Whilst the knowledge of the mass of a glycoprotein or 
glycan may provide initial information regarding composi-
tion, to acquire structural or peptide sequence information 
from glycopeptides, it is necessary to induce fragmentation 
of the glycopeptides of interest via tandem mass spectrome-
try. This is not possible with soft ionization techniques such 
as ESI and MALDI, however, the use of these techniques in 
conjunction with tandem mass spectrometry has allowed the 
structural elucidation of a wide range of glycopeptides and 
their glycan structures [18, 56].  
 Fragmentation of the glycopeptides can be achieved by 
several different methods, which can induce fragmentation 
of both the peptide backbone and the glycan moiety. The 
most common fragmentation technique is collisional induced 
dissociation (CID), sometimes also referred to as collisional 
activated dissociation (CAD), but other complimentary tech-
niques include infrared multiphoton dissociation (IRMPD) 
[57-59], electron capture dissociation (ECD) [58, 60] and 
electron transfer dissociation (ETD) [61]. It has been demon-
strated that in tandem MS of glycans those that are adducted 
with a Na
+ 
or other metal ion rather than merely being proto-
nated provide a larger number of structurally informative 
fragments [62]. 
Collisional Induced Dissociation (CID) 
 In tandem MS peptides are individually ionized in the 
source region using ESI or MALDI. These peptides are then 
further separated, based on their m/z ratio. The selected ions 
are allowed into a collision cell, which is filled with an inert 
gas such as xenon, argon or nitrogen, collisions then occur 
between the precursor ion and inert-gas atoms (molecules). 
In these collisions part of the precursor ion's translational 
energy can be converted into internal energy, and as a result 
of single or multiple collisions an unstable excited state is 
populated. Excited precursor ions decompose to produce 
product ions during collision-induced dissociation [34]. The 
types of fragment ions observed in an MS/MS spectrum de-
pend on many factors that include the primary sequence of 
the peptide, the amount of internal energy and the charge 
state [63].  
 The main types of ions observed in the fragmentation of 
protonated peptides are well established noting that frag-
ments can only be detected if they carry a charge. If the 
charge is retained on the N-terminal fragment the ion is clas-
sified as a, b, or c and x, y, or z if the charge is carried on the 
C-terminus. The nomenclature for fragmentation ions was 
described by Roepstorff [64] and subsequently modified by 
Johnson et al. [63] Fig. (1A).  
 The glycan moiety generally fragments in one of two 
ways, either by fragmentation of the bond between two adja-
cent sugar groups or by cross-ring cleavages occurring via 
rupture of two bonds within the same sugar unit [19, 46]. 
The nomenclature for fragmentation of carbohydrates is also 
well established, ions retaining the charge on the non-
reducing terminus are classified as A, B and C, those that 
retain the charge on the reducing terminus are X, Y and Z. A 
and X are the result of cross-ring cleavages, whereas B, C, 
Y, and Z are the result of glycosidic bond cleavages [65] 
(Fig. 1B).  
 CID for the most part produces fragments from glyco-
peptides that arise from glycosidic bond cleavage providing 
invaluable information on the sequence and connectivity of 
glycopeptides [57, 61]. However, CID has inherent disad-
vantages, the efficiency of fragmentation and also the degree 
of fragmentation decreases with increasing mass of the oli-
gosaccharide. Also a number of successive tandem mass 
spectrometry steps may be required to gain insight into the 
structure of the glycan, and this is tempered with the loss of 
material at each step in CID making interpretation of spectra 
at later MS
n
 more difficult. 
Infrared Multiphoton Dissociation (IRMPD) 
 In IRMPD the ion of interest is isolated and irradiated 
with an infrared laser beam, as the ions absorb energy from 
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the beam they become vibrationally excited, leading to bond 
scission. IRMPD produce fragmentation ions that are, to all 
intense purposes, the same as those for CID [57]. There are, 
however, some advantages, since this process does not de-
pend on resonant energy transfer, the energy imparted to the 
glycopeptide can be more easily controlled, by adjusting the 
laser intensity and the duration of exposure, and since both 
the precursor and fragment ions can absorb the infrared pho-
tons the fragment ions can undergo secondary fragmentation 
providing further structural information without the need for 
further MS
n 
[59, 66]. There is no need for the introduction of 
collision gas, and thus no subsequent perturbation of vacuum 
and loss of resolution. Therefore, IRMPD has a higher duty 
cycle and can do more scans in a given time, resulting in 
more structural information [57, 58]. It has also been demon-
strated, in this process, that the efficiency of fragmentation 
of oligosaccharides is enhanced as the size of the oligosac-
charide increases [67]. This process has also been used to 
obtain structural information from N-linked glycans via 
cross-ring cleavage, generating information, which is not 
readily obtainable using CID [66]. 
Electron Capture Dissociation (ECD) 
 During ECD multiply protonated precursor ions are con-
fined and are irradiated with low energy electrons (<0.2 eV) 
from an electron gun. This causes the peptide to fragment, 
producing [M + nH]
n+
 + e
-? [M + (n-1)H](n-1)+ as the major 
product ion. This species undergoes molecular rearrange-
ment and dissociates into sequence specific products with 
cleavages observed at the polypeptide backbone producing c 
and z• product ions [68, 69]. Within this technique even 
though the backbone of the peptide is fragmented the more 
labile modifications like glycosylation remain intact on the 
polypeptide backbone, enhancing the ability to identify and 
localize the sites of glycosylation. This has great promise 
particularly for the identification of O-linked glycosylation 
sites, which have no consensus sequence [69, 70]. 
Electron Transfer Dissociation (ETD) 
 In ETD a singly charged anion, originally anthracene and 
eventually fluoranthracene is used to transfer an electron to a 
multiply charged peptide or protein. The resulting odd elec-
tron species undergoes subsequent recombination. This re-
sults in the production of c and z fragment ions from the pep-
tide backbone. Thus, labile post-translational modifications 
are conserved, so again, this represents a potential tool for 
localizing sites of glycan attachment [61, 70, 71].  
Glycosylation in Eukaryota 
 Attachment of glycans to the polypeptide backbone of 
proteins occurs via several distinct linkages including N-
linked, O-linked, glycosylphosphatidyl inositol anchors and 
C-glycosylation [72]. The common monosaccharides in-
volved in glycosylation can be seen in Fig. (2). 
 N-linked glycosylation is a highly specific co-
translational reaction that is to say that it occurs during pro-
tein synthesis before the protein is folded into its final con-
formation [73]. In eukaryotes, N-acetyl glucosamine 
(GlcNAc) (5) is linked to the amide nitrogen of an aspar-
agine residue, within the highly conserved consensus se-
quence Asn-X-Ser/Thr, where X may be any amino acid 
apart form proline [14, 38, 72-74]. The ?-glycosamine link-
age between GlcNAc and Asn is the most widely distributed 
carbohydrate-peptide bond in nature [75]. All eukaryotic N-
glycans contain a conserved pentasaccharide core, the tri-
mannosyl chitobiose core, made up of two GlcNAc (5) and 
three mannose (3) units shown in Fig. (3). The different 
permutations of N-glycans in eukaryotes are all manufac-













Fig. (1). (A) Ions generated from the fragmentation of peptides/proteins. (B) Ions generated from the fragmentation of carbohydrates/glycan 
chains. 
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trimannosyl chitobiose core with one or more antennae at-
tached to each of the two outer mannose residues. A number 
of enzymes are then involved in the processing of this struc-
ture through cycles of trimming and addition of carbohydrate 
residues to produce the three main classes of N-glycans 
shown in Fig. (3):  
(1) High mannose – where only mannose residues are at-
tached to the chitobiose core.  
(2) Complex N-glycans - these have had all mannose resi-
dues removed and can have two (biantennary), three (tri-
antennary) or four (tetraantennary) antennae. 
(3) Hybrid N-glycans - where one of the antennae consists of 
only mannose residues [38, 39, 72, 73].  
 O-linked glycosylation in eukaryotes is a simpler process 
than N-glycosylation and is a post-translational event [72, 
73]. There is no known consensus sequence for O-linked 
glycosylation; a variety of monosaccharides can be attached 
to any amino acid with a hydroxyl functional group namely 
serine, threonine, tyrosine, hydroxyproline and hy-
droxylysine [7, 75, 76].  
 Although there is no consensus sequence, ?-linkage of N-
acetyl-galactosamine (GalNAc) (6) to Ser/Thr residues is 
widespread in eukaryotes, with eight associated O-glycan 
core structures [77]. The GalNAc (6) to Ser/Thr linkage is 
found in many cytoplasmic and nuclear proteins [75]. 
Mucins are also associated with these Ser/Thr O-glycans 
found in abundance in tandem repeat domains rich in proline 
[7, 16, 28, 72]. 
 Glycosylphoshatidyl anchors are mainly distributed 
among biologically important cell surface glycoproteins. 
This process involves the linkage of phosphoethanolamine to 
mannose (3), which is then attached to the carboxyl terminal 
of the target protein [72, 75]. 
 C-glycosylation is the only form of glycosylation that 
does not use an amino acid functional group in its bonding. 





















Fig. (2). The structures of common monosaccharides utilized in glycosylation by eukaryotes and prokaryotes. R, R’ and R” represent posi-
tions where different substituents may be attached to give derivatives of the parent monosaccharide. 
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mannose residue (3) binding to the C2 atom of the tryptophan 
side chain [75, 78, 79]. 
Glycosylation in Prokaryota 
 Glycosylation was once thought to be the sole dominion 
of the Eukaryota. It was with the discovery of N- and O-
linked carbohydrates attached to a surface layer protein of 
the halophilic archaeon Halobacterium salinarium in 1976, 
that this long held misconception was dispelled [2, 80-82]. 
Over the following years, a plethora of surface layer and 
non-surface layer glycoproteins have been identified in Ar-
chaea and Bacteria [2, 80, 81, 83] including such milestones 
as the first structural evidence for glycosylation of pili via an 
O-linked trisaccharide in Neisseria meningitidis [84] and the 
first evidence for N-linked glycosylation in bacteria, with the 
identification of an N-linked heptasaccharide on protein 
PEB3 from Campylobacter jejuni [85].  
 N- and O-linked glycosylation events have been found to 
be widespread in Prokaryota. There are important distinc-
tions between eukaryotic and prokaryotic glycosylation 
events. In prokaryotic glycosylation, the common structural 
units such as the chitobiose core and antennae are not neces-
sarily present [86]. This is aptly demonstrated by a number 
of Archae that directly link their glycan chains to S-layer 
proteins by N-glycosidic linkages for example Glc (2) to Asn 
[87] and GalNAc (6) to Asn in the case of Halobacterium 
salinarium [82] and Rha (7) to Asn for the Archae Metha-
notrix soehngenil [88] and this process has also been ob-
served in bacteria in Bacillus stearothermophilus [87, 89]. 
Whilst a number of prokaryotes have the eukaryotic N-
glycosylation consensus sequence Asn-X-Ser/Thr, in Cam-
pylobacter jejuni this has been found to be extended to 
Asp/Glu-Y-Asn-X-Ser/Thr, where X and Y can be any 
amino acid but proline [90]. In fact, the optimal sequence 
was found to be Asp-Gln-Asn-Ala-Thr [91].  
 Also prokaryotic N-linked glycosylation is not always via 
GlcNAc (5) to Asn. In the case of Campylobacter jejuni the 
linkage to the Asn is via a unique bacterial sugar Bac (8), a 
derivative of bacillosamine [92]. 
 Whilst a number of prokaryotes conform to the common 
eukaryotic GalNAc (6) O-linked glycosylation at Ser/Thr 
[93], there are instances, where different consensus sequence 
sites such as mannose (3) linked D-S* and D-T*-T in 
Chryseobacterium meningosepticum [94] and V-Y* in 
Thermoanaerobacter kivui (* denotes site of attachment) 
have been identified [95]. 
 Prokaryotic protein glycans are composed of far more 


















Fig. (3). The three main classes of N-glycans in Eukaryotae: high mannose, hybrid and complex type.       Mannose residues     (3),        Ga-
lactose residues (1),         N-acetyl-glucosamine (5),        Fucose residues (4), *a number of varying carbohydrate constituents can be added to 
these antennae. 
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systems (8-11) Fig. (2) [2, 96]. This significantly compli-
cates carbohydrate structure determination in prokaryotes. 
Despite this restriction prokaryotic ‘glycomics’ has literally 
exploded in the last decade [96]. This heightened interest is 
due in part to the large number of glycosylation events that 
have been identified and associated with human pathogens, 
such as Campylobacter jejuni, Helicobacter pylori, Nesseiria 
gonorrhoea, Pseudomonas aeruginosa and Mycobacterium 
tuberculosis to name but a few [2, 14, 81, 96, 97]. It has been 
shown that these glycosylated proteins are involved in 
pathogenicity, adhesion and immune evasion of these bacte-
ria [11, 98-100].  
 Although Prokaryotes lack cellular organelles similar 
processes for glycan biosynthesis are conserved between 
them and the Eukaryotes. For example the separation of the 
respective pathways by cellular membranes and the use of 
nucleotide activated carbohydrates and membrane bound 
intermediates as well as the transfer of the glycans to similar 
consensus sequences on target proteins [97]. However, there 
are also a number of differences between the prokaryotic and 
eukaryotic glycosylation systems including additional enzy-
matic processing steps that take place within the Endoplas-
mic Reticulum and Golgi Apparatus of the Eukaryotes. This 
review will focus on prokaryotic glycosylation. For more 
detailed information on eukaryotic glycosylation the reader 
is directed to the reviews of Reuter and Gabius [1] and 
Weerapana and Imperiali [101]. 
ANALYTICAL ENRICHMENT TECHNOLOGIES 
 Post-translational modifications are often found at sub-
stoichiometric levels making their identification and analysis 
particularly difficult [102]. This is especially true of glyco-
proteins and glycopeptides, which often are in low abun-
dance with their non-glycosylated counterparts in complex 
mixtures. Therefore, some sort of enrichment techniques 
need to be employed to purify and concentrate these glyco-
forms prior to mass spectrometry analysis [103].  
Lectins 
 Lectins are a widely used tool in research into carbohy-
drate chemistry, traditionally they have been used for histo-
chemical detection of sugar chains on cell surfaces [104, 
105]. These multivalent proteins are becoming increasingly 
prevalent as analytical tools in glycoproteomics due to their 
unique affinity towards carbohydrate epitopes by recogniz-
ing not only specific residues but also being able to distin-
guish between linkage and terminal modifications of com-
plex oligosaccharide chains [106-108]. There are large arrays 
of lectins used in the analysis of glycoproteins and peptides, 
for the capture of N-linked glycans, two with the broadest 
applicability are Concanavalin A (ConA) and Wheat Germ 
agglutinin (WGA), whilst for the capture of O-linked gly-
cans Jacalin is widely used. 
 Con A was first isolated by Sumner from the Jack bean 
(Canavalia ensiformis) in 1919 [109]. It has been shown to 
bind predominantly to ?-D-mannose (3) [110], which is 
prevalent in eukaryotic N-linked glycans. It has a marked 
preference for the ?-configuration at the C-1 position of the 
D-pyranose ring. It has a general propensity for ?-D-
mannosyl (3) and ?-D-glucosyl (2) residues at the non-
reducing termini of oligosaccharides although certain non-
terminal ?-D-mannosyl (3) and ?-D-glucosyl (2) residues 
have also been seen to bind. Con A has been widely studied 
and has been shown to exist as a dimer below pH 5.5 and a 
tetramer with a total of four binding sites above pH 5.5 
[111]. 
 WGA was identified during work carried out on tumor 
cells by Aub and colleagues [112]. It is a dimeric protein 
with four binding sites that has specificity for GlcNAc (5) 
and its ?-(1?4) linked oligosaccharides and analogous sug-
ars [113]. It has also been shown to have affinity for sialic 
acid (neuraminic acid) (9) [111], which is present in a wide 
variety of glycans as an end cap bonded to Gal (1) or Gal-
NAc (6) [105]. 
 Jacalin is another lectin of interest that was isolated from 
seeds of the Jackfruit (Artocarpus integrifolia) [114]. Jacilin 
is a tetrameric protein that has specificity towards ?-D-
Galactose (1) and ?-D-Galactose (1) attached to GalNAc (6) 
[115] and has been found to bind to Gal (1) ?-(1?3) Gal-
NAc (6)-? Ser [116] and as such is used in the capture of O-
linked glycans. 
 These (and other) lectins can be used separately, or as 
was first demonstrated by Yang and Hancock [111] can be 
combined together to produce multi-lectin affinity columns, 
which can be used to enrich for a number of O- and N-linked 
glycoproteins present in a sample prior to MS analyses 
[117]. Madera et al. [107] have also attempted to take this 
lectin binding technology for the analyses of glycopeptides a 
step further by coupling it directly online to the mass spec-
trometer by producing lectin microcolumns that can be di-
rectly incorporated into MS front-end configurations. Work 
is even ongoing on the production of multiple lectin ‘micro-
arrays’ to try and carry out large scale capture of as wide a 
proportion of the glycome, as possible, in a single experi-
ment [118]. 
Graphite Carbon Column Chromatography 
 Charcoal columns have been used for the separation of 
oligosaccharides since the 1950’s [119]. These, however, 
were not robust enough to be applied to HPLC techniques. 
The advent of Graphite Carbon Chromatography columns 
(GCC) enabled Koizumi and co-workers to use these col-
umns for the resolution of carbohydrates including mono-
and disaccharides as well as isomeric and even different 
anomeric forms [119]. The column retention appears to be 
based on both the carbohydrate and peptide portions present 
in glycoproteins and glycopeptides [120]. These columns are 
now widely used in glycomic/glycoproteomic research inter-
faced directly online to the mass spectrometer [121] for the 
analysis of N- and O-linked glycans [122] and have even 
recently been adapted in a Chip format for the Agilent mass 
spectrometers [123]. 
Hydrophilic Interaction Chromatography 
 Hydrophilic interaction chromatography (HILIC) has 
been used for the analysis of sugars and oligosaccharides 
since the 1970’s [124] and efficient high resolution separa-
tion of glycans and glycopeptides can be achieved using 
amine and amide based columns [77, 125]. The glycans in-
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teract with the hydrophilic (polar) stationary phase through 
H-bonding, ionic interactions and dipole-dipole interactions 
[125] and are eluted from the column in a solution of organic 
modifier and water, where increasing concentrations of water 
are used to remove the glycans [125]. Guile et al. [126] 
demonstrated that by labeling the reducing ends of glycans 
by reductive amination followed by separation on a HILIC 
column, it was possible to simultaneously resolve subpico-
molar mixtures of neutral and acidic glycans. For structural 
characterization of the glycans their elution positions from 
the HILIC column were calculated in glucose units with 
reference to a dextran ladder [126]. HILIC of underivatized 
glycans has also been directly interfaced online in the 
nanoLC format enabling the detection of oligosaccharide 
mixtures at low-femtomole sensitivity [127]. The same 
group also analyzed glycopeptides by this methodology 
[128]. HILIC micro columns have also been used for the 
capture of glycopeptides from N-glycosylated proteins with 
subsequent direct release onto MALDI target plates for di-
rect MS analysis [129]. 
Reversed Phase Chromatography 
 Native carbohydrates are not particularly well retained on 
reversed phase (RP) HPLC columns, however, derivatization 
of the glycans by either permethylation or reductive amina-
tion renders them more hydrophobic and, therefore, amena-
ble to RP separation, with the added advantage that the RP 
column can be directly coupled to the mass spectrometer [39, 
46]. The separation of the glycans is based mainly on the 
hydrophobicity of the tag. As the size of the glycan in-
creases, so does the hydrophilicity of the tag, thus the larger 
the tagged glycan the less effectively it binds to the column 
[77, 130]. 
Periodate Oxidation Coupled to Hydrazide Resin Cap-
ture 
 Periodate oxidation allows for the identification of sites 
of N-linked or O-Linked glycosylation. As illustrated in Fig. 
(4), in this process the vicinal cis-diol groups of carbohy-
drates in a glycan chain are converted to aldehydes, these in 
turn are reacted with immobilized hydrazide groups on a 
solid support forming a covalent bond. The immobilized 
glycoprotein undergoes proteolysis on the support and non-
glycosylated peptides are removed. At this point the attached 
glycopeptide can be isotopically labeled for quantitative 
analysis and ?-amino groups of lysines are guanidinated to 
form homoarginines, facilitating detection by MS. The N-
linked glycopeptides are then released from the column us-
ing PNGase F and are identified by mass spectrometry. O-
linked glycopeptides can be released by ?-elimination [131] 
or with a number of unspecific enzymes [132, 133]. 
?-Elimination Followed by Michael-Addition (BEMAD) 
 A number of groups have used ?-elimination followed by 
Michael-addition to introduce functional groups into the sites 
of phosphorylation and O-linked glycosylation in peptides. 
This enables both the labeling and separation of the peptides 
in order to aid in the mapping and identification of these 
sites [134, 135]. In an interesting extension of this process 
Wells et al. [102] developed a methodology that was di-
rected specifically towards O-linked glycan labeling and not 
phosphorylation site labeling. In this technique the O-linked 
glycans undergo mild ?-elimination followed by Michael 
addition with dithiothreitol effectively adding an affinity tag 
to the site of O-glycosylation allowing the labeled peptide to 
be captured and the site of glycosylation accurately mapped.  
GLYCAN RELEASE 
 Given the different linkage chemistries involved in the 
attachment of O- and N-linked glycans, different approaches, 
either enzymatic or chemical, must be taken to release the 
intact oligosaccharide chains [72]. 
N-linked Glycan Release 
 From its identification [136] to its purification [137] the 
most widely used enzyme for release of N-linked glycans 
has been peptide-N-glycosidase-F (PNGase F). This enzyme 
cleaves the amide bond between the asparagine and the gly-
cosyl amine, releasing the glycosyl amine, which is readily 
converted to a glycan with a reducing end (aldehyde func-
tional group) [77, 137]. Cleavage by PNGase F leads to the 
conversion of asparagine to aspartic acid, therefore effec-
tively labeling the sites that had been occupied by the glycan 
structure [44, 72]. However, care must be taken when inter-
preting these data since hydrolysis of aspartic acid is a com-
mon side reaction leading to asparagine and thus potential 
misinterpretations [138, 139]. PNGase F releases most Asn 
N-linked glycans from their proteins, unless there is ?(1?3) 








Fig. (4). Periodate oxidation and hydrazide resin capture of glycopeptides. R and R? groups represent glycan chains and polypeptide chains. 
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a number of prokaryotes the N-linkage, rather than occurring 
through GlcNAc (5), is via an unusual sugar moiety. This is 
the case in Campylobacter jejuni where the N-linkage is 
through di-acetyl bacillosamine (8) and PNGase F has no 
effect as it does not recognize this sugar as a substrate [140]. 
In this case Liu et al. [141] have developed a strategy using 
the enzyme Pronase E that results in the production of Asn 
linked glycans that can be further derivatized and studied.  
 A chemical method for the release of N and O-linked 
glycans is by hydrazinolysis shown in Fig. (5). This method 
releases the glycans, but the peptide bonds are destroyed 
leaving no information on the protein or peptide to which the 
glycan was attached. Also information on N- and O- acetyl 
and N-glycosyl substituents of sialic acid (9) modifications 
can be lost [39, 142, 143]. 
O-linked Glycan Release 
 Unlike PNGase F for N-linked glycan analysis, there is 
no broad specificity ubiquitous enzyme for the release of O-
linked glycans. A number of exoglycosidases need to be 
used to reduce the glycan chain to the Gal (1) 
?(1?3)GalNAc (6) core attached to Ser/Thr, that can then 
be released by O-glycosidase [131-133]. Not all O-linked 
glycans, particularly those present in prokaryotes, contain 
this core structure. Therefore, O-linked glycans to Ser/Thr 
are usually released by chemical methods, the most common 
of which involves ?-elimination under alkaline conditions in 
the presence of excess sodium borohydride (NaBH4), also 
termed ‘reductive’ ?-elimination.  
 The ?-elimination converts Ser/Thr glycan linked amino 
acids to unsaturated hydroxyamino acids, however, the pres-
ence of the NaBH4 ultimately reduces the unsaturated hy-
droxyamino acids to alanine and 2-aminobutyric acid. Deg-
radation of peptides is common in ?-elimination and obtain-
ing sequence information can therefore be difficult [144]. 
The common addition of NaBH4 also prevents ‘peeling’ of 
the released glycans by conversion of the terminal GalNAc 
(6) residue to its alditol (see Fig. (6)) [7, 39, 46]. During 
‘peeling’ single monosaccharides are removed sequentially 
from the reducing end of the glycan chain. This is due to 
rearrangement under alkaline conditions of the reducing ter-
minal to the keto form, followed by glycosidic bond scission 
[145]. Due to the conversion of the glycan to the alditol it 
cannot be further derivatized using reductive amination [77], 
which is commonly used for further glycan characterization. 
Using this ?-elimination methodology - due to the presence 
of NaBH4 - there can also be a significant release of N-
glycans [146].  
GLYCAN DERIVATIZATION 
 Glycans that have been released from their peptide or 
protein by enzymatic or chemical processes will contain a 
reducing terminus. One of the problems in the mass spec-
trometric analysis of these glycans is that due to the diversity 
of their composition and the presence, in many cases, of ace-
tyl and acidic residues, the glycan moieties do not readily 
ionize [147, 148]. Thus derivatization of the glycan moieties 
is often performed prior to MS analyses.  
Permethylation 
 One of the most commonly used techniques is to derivat-
ize the carbohydrate to form acid stable methyl esters [149]. 
The most widely used method for the complete methylation 
(per-methylation) of carbohydrates was initially developed 
by Hakomori in 1964 [150]. This permethylation technique 
replaced previous techniques as it could be carried out 
quickly and efficiently. In this method the methylsulfinyl 
carbanion, produced from NaH/NaOH and DMSO, acts as a 
strong base, deprotonating all the labile sites on the carbohy-
drate, -OH, -NH2 and -COOH. Methylation of these sites 
then occurs rapidly in the presence of methyl iodide shown 
in Fig. (7). All hydroxyl, carbonyl and amino groups are 
converted to methyl esters and all N-acyl groups are N-
methylated [149, 151].  
 There have been a number of improvements to the origi-
nal method, particularly the simplified approach of Ciucanu 











Fig. (5). Hydrazinolysis of glycopeptides/proteins. ? Glycan chains. 
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glycans that ionize more efficiently and with significantly 
improved sensitivity, than their underivatized native forms. 
The improvement in glycan ionization is due to a combina-
tion of the highly polar hydroxyl and carboxyl groups being 
converted to non-polar derivatives and sialic acid (9) resi-
dues also being stabilized by the removal of the highly acidic 
proton on their carboxyl groups [46, 148, 153, 154]. The 
permethylation process also aids in the sample clean-up of 
these derivatized glycans prior to MS as the addition of the 
methyl groups make the glycans more hydrophobic and, 
therefore, amenable to separation and desalting via RP sepa-
ration [46]. Another advantage of this derivatization is that 
the fragmentation pathways are much more informative and 
predictable leading to ions that can be unambiguously as-
signed to unique features [154].  
 This technique is also used widely in the establishment of 
the position of glycosidic linkages between sugar residues 
[149, 155]. The advantage here is that the glycosidic linkage 
oxygen will not be methylated. The fragmentation ions can 
be analyzed by tandem MS and the linkage site, where the 
glycosidic bond was, lacks the mass of the methyl group and, 
therefore, the linkage position can be established [62]. An-
other approach is to reduce the glycan to its alditol using 
NaBH4, then permethylate it and the linkage to the reduced 
sugar can then be determined from the fragmentation of the 
alditol moiety [38, 155]. 
Reductive Amination  
 Reductive amination is another method used for the de-
























Fig. (6). Reductive ?-elimination of O-linked glycans.  ? Glycan chains. 
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added to the reducing end of the glycan by reductive amina-
tion with an aromatic amine, such as the natural amino acid 
analogue 2-aminobenzoic acid. These aromatic amines can 
be fluorophores or chromophores and their addition leads to 
increased sensitivity for these derivatives and also enhanced 
MS signal intensity [39]. Fig. (8) illustrates the widely used 
scheme for reductive amination via Schiff base. The Schiff 
base formation is facilitated by the presence of an acid and 
the amine acts as a free base during the protonation of the 
carbonyl oxygen, once the Schiff base is formed it is then 
reduced, usually with cyanoborohydride (NaBH3CN) to ob-
tain the stable derivative [77]. This method works well for 
enzymatically released N-linked glycans and glycans that 
retain a reducing end but it is not amenable to O-linked gly-
cans that have been released via reductive ?-elimination, as 
the aldehyde group will have been reduced to an alcohol 
[38]. 
GLYCOINFORMATICS 
 One of the goals of glycoproteomics is to have the ability 
to analyze intact glycopeptides and to provide both peptide 
sequence and structural information on the attached glycan 
[156]. However, glycoproteomics places a huge burden on 
the researcher, generating large amounts of mass spectral 
data [16]. A major restriction here is the lack of rapid accu-
rate automated tools for the retrieval of structural informa-
tion from this MS data [18]. Without such tools each mass 
spectrum must be manually annotated by an expert, a task 
that is not too cumbersome with one spectrum but which 
becomes colossal in magnitude when applied to a full LC-
MS/MS run [6]. For an in-depth analysis of these problems 
and the approaches being used to tackle them, the reader is 
directed to the reviews of Pérez & Mulloy [6, 157] and Aoki-
Kinoshita [6]. 
 In order to aid research in glycomics and glycopro-
teomics, several databases have been developed that contain 
structural data on complex glycans: Consortium for Func-
tional Glycomics (http://www.functionalglycomics.org/gly-
comics/common/jsp/firstpage.jsp), the Kyoto Encylopedia of 
Genes and Genomes glycome information resource 
(htpp://www.genome.jp/keg/glycan/), the Japanese Consor-




























Fig. (8). Labeling of glycan chains by reductive amination. R group can be a number of different substituents. 





 There has also been the production of databases of theo-
retical mass spectra corresponding to known glycan struc-
tures that can be used for comparison with generated mass 
spectra such as Glyco-Fragment and GlycoSearchMS [158]. 
 The production of GlycoWorkBench [159] to provide 
support for the routine semi-automated interpretation and 
assignment of glycomic MS spectra has been of immense aid 
to researchers in this field. This software provides a free easy 
to use graphical interface, and visual editor based on Gly-
canBuilder [160] for the interpretation of MS data. 
 The development of Cartoonist allowed for the first com-
prehensive attempt to automate the analysis of intact per-
methylated glycans. The system selects plausible annotations 
from a library, the system then determines the precision and 
calibration of the mass spectrometer used to generate the 
data and then assigns a confidence score to the most likely 
glycan structures and annotates the appropriate peaks in the 
mass spectrum [161]. The problem with these databases is 
that they are only applicable to the identification of glycans 
after release from and generally with prior knowledge of the 
peptide it was attached to. 
 The latest generation of bioinformatics programs, Pep-
toonist an extension of the Cartoon program [162], Gly-
coMiner [163] and Branch-and-Bound [156] are now capable 
of providing information on the sequence of N-glycopeptides 
and the structure of its glycan attachments. 
ROLE OF GLYCOSYLATION IN Campylobacter sp. 
 Campylobacter jejuni and Campylobacter coli are recog-
nized as the most common causative agents in human en-
terocolitis and are one of the main causes of severe bacterial 
diarrheal disease in humans. They account for more cases 
worldwide than those due to Salmonella sp., Shigella sp., or 
Escheria coli. In the United States over 99% of reported in-
fection with Campylobacter are from C. jejuni. In develop-
ing countries the incidences of Campylobacter infection are 
estimated at about 800 notifications per 100,000 population. 
In tropical developing countries Campylobacter infection is 
hyper-endemic among young people causing high mortality 
rates in children and infants. Several studies estimate infec-
tion rates in the under fives to be as much as 60,000 per 
100,000 population [100, 164-167]. This bacterium is com-
mensal in both poultry and cattle, with birds acting as its 
natural reservoir. Human infection generally occurs from the 
consumption of contaminated food or water [167, 168]. 
 The flagellin of Campylobacter are the most heavily gly-
cated bacterial proteins described to date and these species 
also produce a number of other glycated proteins that are 
destined for deposition on the cell surface or to be secreted 
[13]. These glycosylated proteins have been demonstrated to 
be highly immunogenic in nature [12]. They have been 
shown to play pivotal roles in virulence, microcolony forma-
tion and resistance to acid phagocytosis [13] as well as me-
diating the ability of C. jejuni to adhere to and invade cells in 
vitro and to colonize the intestinal tract of mammals [11, 12]. 
O-Linked (Flagellin) Glycosylation: Pseudaminic and 
Legionaminic Acid 
 Flagellins of Campylobacter bacteria are the immuno-
dominant antigen during infection and are involved in the 
colonization of the GI-tract. Thus, investigation of these 
flagellins may provide insights into the capability of these 
organism to cause disease and may also lead to the elucida-
tion of mechanism to inhibit or inactivate their ability to 
colonize and cause disease in hosts [169].  
 In C. coli VC167 two variants were identified that pro-
duce different flagellins. These were identified as T1 and T2 
based on reactions with specific polyclonal antibodies. The 
genes for both were cloned and consist of two flagellin 
genes, flaA and flaB. Both gene products of flaA and flaB 
must be expressed in Campylobacter sp. to produce a fully 
active flagellum [169]. The predicted masses for these gene 
products were all between 58-59 kDa. Migration on SDS-
PAGE gels showed that the masses were, in fact, much 
higher, suggesting that they were post-translationally modi-
fied. 
 Further evidence for the post-translational modification 
of these flagellins was the observation that the antigenic na-
ture of the flagellin is based on the genetic background of the 
host strain and not the specific flagellin gene. Also, of the 
genes required for the synthesis of this post-translational 
modification, one had high sequence homology to N-acetyl 
neuraminic acid (Neu5Ac) synthetase in Neisseria and Es-
cherichia coli, which is involved in the synthesis of capsular 
sialic acid (Neu5Ac) (9) [170]. 
 Doig et al. [165] examined the flagellin of C. coli, C. 
jejuni and C. fetus. The first evidence that this post-
translational modification was glycosylation was shown by 
the fact that the flagellin in all species underwent mild perio-
date oxidation producing free aldehydes, which were then 
able to be hydrazine biotinylated. The presence of terminal 
sialic acid (9) residues was also confirmed, using an adapta-
tion of this method, where binding of flagellin only occurred 
in the presence of sialic acid (9) binding LFA (Limax flavus 
agglutinin) lectin. The inability of LFA to completely re-
move antigenicity, however, indicated that other molecules 
were also involved in sero-specificity; the fact that tuni-
camycin, an N-linked glycosylation inhibitor failed to pre-
vent flagellin glycosylation suggested that this was an O-
linked process [165]. 
 Fry et al. cloned a number of genes that had significant 
homology to enzymes involved in lipopolysaccharide (LPS) 
biosynthesis, from C. jejuni 81116 into E. coli. Lipopolysac-
charides are an abundant component of the outer membrane 
of Gram-negative bacteria that are involved in modulation of 
host immune response [100]. However, a further study using 
site specific mutations of these genes from C. jejuni 81-176 
demonstrated that at least in Campylobacter they did not 
play any role in LPS biosynthesis. Rather, based on sequence 
homology of the genes in 81-176, they were classified as 
protein glycosylation pgl genes. PglE&F showed significant 
homology to flagellin modification Flm genes FlmB&A, 
which were involved in glycosylation of flagellin in other 
bacteria. PglB had significant homology to an oligosaccha-
ride transferase involved in protein glycosylation in yeast. 
PglA is homologous to a galactosyl transferase in the 

































Fig. (9). The CMP-Pseudaminic and CMP-Legionaminic pathway. The pathways begin with PtmF&A acting in concert to convert fruc-
tose-6-P to glucosamine-6-P. PglM (Cj1407c) acts as a phosphoglucomutase converting glucose-6-P to glucosamine-1-P.  
CMP –Pse biosynthetic pathway: The full process starts with GlmU proposed to produce UDP-GlcNAc from glucosamine-1-P, the C-4,6 
dehydration and C-5 epimerization of UDP-GlcNAc by PseB forming UDP-4-keto-6-deoxy-AltNAc, C-4 aminotransferase of this by PseC 
forms UDP-4-amino-6-deoxy- AltNAc, N-4 deacytylation of this by PseH forms UDP-2,4-diNAc-6-deoxy-Alt, removal of UDP from C-1 of 
this by PseG produces 2,4-diNAc-6-deoxy-Alt condensation of this with pyruvate by PseI forms pseudaminic acid (13) and finally activation 
of this with CMP by PseF forms CMP-pseudaminic acid, ready for attachment to Ser/Thr groups at the appropriate surface exposed regions 
on flagellin in the cytoplasm. 
CMP-Leg biosynthetic pathway: PtmE acts as the nucleotidyl transferase adding GTP to glucosamine-1-P producing GDP-GlcN. With the 
initial GDP sugar produced the acetylation of this is the next step, here GlmU is proposed to produce GDP-GlcNAc, but other enzymes may 
be involved. LegB acts as a dehydratase forming GDP-4-keto-6-deoxy-GlcNAc. LegC catalyzes the amino transfer of this to produce GDP-4-
amino-6-deoxy-GlcNAc. LegH (Cj1298) acts as the N-acetyltransferase converting this to GDP-2,4-diNAc-6-deoxy-Glc. LegG then performs 
a C2 epimerization resulting in the removal of the GDP to form 2,4-diNAc-6-deoxy-Man. LegI (Cj1327) catalyzed the condensation of this 
with pyruvate to form legionaminic acid (16). LegF (Cj1331) then catalyzed the addition of CMP to give the activated legionaminic acid for 
attachment to flagellin. 
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trisaccharide modification of pilin in N. meningitidis. This 
research also showed that the carbohydrate components at-
tached to proteins were immunogenic in nature, including 
those of flagellin proteins [12]. 
Elucidation of the Pseudaminic Acid Biosynthetic Path-
way 
 The proposed biosynthetic pathway for the production of 
cytidine monophosphate (CMP)-pseudaminic acid is shown 
in Fig. (9). 
 Although C. jejuni enteritis is somewhat debilitating in 
healthy individuals it also tends to be self-limiting. More 
serious conditions that can arise from C. jejuni infections 
include Guillain-Barré syndrome, which is the most common 
cause of acute flaccid paralysis in the United States [171] 
and Miller-Fisher syndrome. These diseases result in damage 
to the nerve gangliosides by antibody mediated axonal cy-
toskeletal breakdown and peri-synaptic Schwann cell dam- 
age. They are considered to be true cases of molecular mim-
icry mediated diseases, particularly related to antecedent 
Campylobacter jejuni infection. The link between these neu-
ropathies and C. jejuni is thought to come about due to the 
bodies’ production of antibodies against C. jejuni lipopoly-
saccharides (in C. jejuni these are analogous to lipo-
oligosaccharides of mucosal pathogens), which cross-react 
with gangliosides. It is believed that lectin-binding proteins 
within the immune system recognize glycan binding sites on 
pathogens and activate the complement system thus produc-
ing these cross-reactive antibodies [171, 172]. This cross-
reactivity is thought in part to be due to the presence of N-
acetyl neuraminic acid (Neu5Ac) (9) that is displayed in 
prominent positions on vertebral cells and is critical for a 
number of physiological processes including neuronal plas-
ticity [173], and is also found on the oligosaccharide portion 
of C. jejuni cell surface proteins. Investigation of glycopro-
teins and their associated glycans may help elucidate the 
mechanisms of this cross-reactivity and provide leads for 
new therapeutic intervention for C. jejuni infections.  
 Three putative Neu5Ac (9) synthetase genes were pre-
dicted from analysis of the C. jejuni NCTC 11168 genome 
sequence. NeuB encodes Neu5Ac (9) synthetase, which ca-
talyses the formation of Neu5Ac (9) from N-acetyl-D-
mannosamine (12) and phosphoenolpyruvate. NeuB2 
(Cj1327) and neuB3 (Cj1317) were found to be part of a 
nineteen gene cluster from Cj1317 to Cj1337. Adjacent to 
this cluster were found the flagellin structural genes flaA&B. 
These genes were thus hypothesized to play a role in the 
post-translational modification of the flagellin subunit [168]. 
 NeuB1 (Cj1141) was identified as the gene responsible 
for lipo-oligosaccharides sialylation within C. jejuni NCTC 
11168. GC-MS analysis of purified lipo-oligosaccharides 
confirmed that a peak corresponding to Neu5Ac (9) was pre-
sent at 23 minutes in the wild type trace but absent in the 
neuB1 mutant. Also FAB-MS of permethylated lipo-
oligosaccharides showed that the carbohydrate portions of 
wild type and mutant lipo-oligosaccharides differed by the 
equivalent mass of a trisaccharide comprising Neu5Ac (9)-
Hex-HexNAc with the hexose likely to be galactose (1) 
[174]. The sequencing of the C. jejuni NCTC 11168 genome 
in 2000 showed two large regions lower in G+C content that 
encompass Cj1135-Cj1148 and Cj1421-Cj1442 the lipo-
oligosaccharides and extracellular (capsular) protein biosyn-
thesis gene clusters [168]. There were also found to be varia-
tions in the lengths in polyG:C (homopolymeric) tracts in 
certain parts of the genome that lead to slipped-strand mis-
pairing during replication, which can affect translation and 
has been shown to be responsible for phase variation of sur-
face proteins and antigenicity. Interestingly, the majority of 
the hypervariable regions were to be found in the gene clus-
ters responsible for lipo-oligosaccharide biosynthesis, ex-
tracellular/capsular protein biosynthesis and flagellar modi-
fications. Some of these variable genes could be assigned 
possible functions, such as Cj1139 encoding a ?-(1?3)-
glycosyltransferases. A number of others were found to be 
associated with two families, 617 and 1318. The 617 family 
consists of five members Cj617/618, Cj1305c, Cj1306c, 
Cj1310c and Cj1342c, four of which are located in the flag-
ellin glycosylation gene locus. There are no homologues of 
the 617 found outside C. jejuni. However, the 1318 family, 
at least in enterobacteriaceae are found within lipo-
oligosaccharide gene clusters [98, 168]. These seven genes 
were found to be involved in variation of motility and were 
termed motility accessory factors (maf): Cj1318 (maf1), 
Cj1333 (maf2), Cj1334 (maf3), CJ1335/6 (maf4), Cj1337 
(maf5), Cj1341 (maf6) and Cj1342 (maf7) [169]. 
 The use of mass spectrometry in the analysis of O-linked 
glycosylation in Campylobacter sp. was indispensable in the 
extensive analysis of Campylobacter sp. flagellin carried out 
by Thibault and co-workers [175]. In this study flagellin 
were isolated from three C. jejuni species and one C. coli 
species. The intact flagellins were subjected to MS analyses, 
whilst flagellin glycopeptides were subjected to MS and tan-
dem MS analyses before and after ?-elimination. Analysis of 
the intact Campylobacter flagellin demonstrated that at least 
10% of the mass of the flagellins was due to the attachment 
of glycan moieties. Analysis of the tryptic peptides derived 
from the purified flagellin identified three unexpected modi-
fications of the peptides relating to species of masses 317 
m/z (316 Da), 316 m/z (315 Da) and 409 m/z (408 Da). Ac-
curate mass measurements were obtained for the oxonium 
ion relating to the 316 Da modification; the exact mass was 
found to be 316.122 ± 0.004 Da. The tandem MS spectrum 
of this moiety was characterized by the loss of neutral groups 
such as water, ketene and formic acid. These experiments 
indicate that the unusual glycan was a diamino sugar con-
taining an acid group with two N-acetyl functionalities and a 
modified C7 side chain. This was identified as pseudaminic 
acid (Pse5Ac7Ac) (13); a unique nine carbon bacterial car-
bohydrate shown in Fig. (10); and not, as had been previ-
ously thought sialic acid (9) [165]. 
 The 316 m/z ion corresponding tandem MS spectrum 
showed losses consistent with the substitution of one of the 
two acetamido groups by an acetoamidino group, which re-
sulted in a glycan moiety 1 Da lower than that for pseu-
daminic acid (Pse5Ac7Ac) (13) and was termed 5-
acetamidino-7-acetamido-Pse (Pse5Am7Ac) (15). The 408 
moiety was shown to have a mass difference of 92.027 Da to 
the pseudaminic acid residue and was consistent with the 2 
N-acetyl groups being substituted for 2 N-2,3-
dihyrdroxypropionyl groups (Pse5Pr7Pr) (14) (see Fig. (10)).  
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 To determine the sites of O-linked glycosylation, the pu-
rified glycopeptides were subjected to ?-elimination. Ten 
sites were identified as glycated by MS and a further nine 
were assigned using Edman sequencing. Most of these sites 
were localized in a region of the flagellin that was surface 
exposed. This work also identified the previously unknown 
functionality of the gene product Cj1316c (PseA) as respon-
sible for the conversion of pseudaminic acid to 5-
acetamidino-7-acetamido-Pse (15) [175]. The gene Cj1293 
(pseB) was found to be central in flagellin glycosylation with 
pseudaminic acid (Pse5Ac7Ac) (13) and in flagellum assem-
bly. PseB mutants were found to be non-motile, with accu-
mulation of unglycosylated flagellin intracellularly. Flagellin 
taken from wild type and mutant were digested and sub-
jected to tandem MS, only in the wild type was the charac-
teristic 317 m/z pseudaminic acid oxonioum ion observed. 
Complementation with pseB restored motility and glycosyla-
tion patterns. PseB was found to have a high degree of ho-
mology to a H. pylori Urididine diphosphate (UDP)-GlcNAc 
C6-dehydratase. When this protein was introduced into the 
pseB mutant, tandem MS analysis revealed the presence of 
the 317 m/z oxonium ion and 66% restoration of glycosyla-
tion, suggesting that pseB is a UDP-GlcNAc C6-dehydratase 
involved in the production of pseudaminic acid. [167, 176]. 
Further studies proved that pseB in fact produced UDP-4-
keto-6-deoxy-N-Acetyl-altrosamine (AltNAc), from UDP-
GlcNAc, the first precursor in the production of pseudaminic 
acid (13) [177]. PseC (Cj1294c) was shown to use UDP-4-
keto-6-deoxy-AltNAc as a substrate to produce UDP-4-
amino-6-deoxy-AltNAc [167]. These findings were corrobo-
rated by a separate study that same year carried out on dehy-
dratase and aminotransferase proteins from Campylobacter 
and homologous proteins in Helicobacter [178].  
 In an effort to further enhance knowledge of O-linked 
pseudaminic acid glycosylation Guerry et al. [13] selectively 
created knockout mutants of the flagellin glycosylation locus 
in C. jejuni 81-76. This species has only 21 of the 50 pro-
posed genes involved in the bacterial glycosylation locus of 
C. jejuni NCTC 11168. Only nine mutations affected modi-
fication of the flagellum with pseudaminic acid 
(Pse5Ac7Ac) (13) or its derivatives. Mutation of pseB, pseC, 
pseF, pseI/neuB3 (involved in pseudaminic acid (13) biosyn-
thesis) and pseG, pseH and pseE (whose function were un-
known at the time) all resulted in non-motile phenotypes. 
Based on homology to the sialic acid (9) biosynthetic path-
way pseF was proposed to attach pseudaminic acid (13) to 
CMP converting it to its activated form for attachment to 
polypeptide backbones.  
 There was also a loss of the acetamidino derivative of 
pseudaminic acid (15) oxonioum ion (316 m/z) in pseA and 
pseD mutants, whilst still being evidence for the presence of 
pseudaminic acid (13), suggesting that both genes are in-
volved in biosynthesis of acetamidino derivatives of pseu-
daminic acid (15) from pseudaminic acid (13) and its subse-
quent transfer to flagellin. Of the five maf homologs only 
pseD&E had an observable effect on flagellin. All the mu-
tants resulting in the loss of acetamidino derivatives of pseu-
daminic acid (15) from the flagellin failed to auto-
agglutinate, a critical process for virulence, microcolony 
formation, and resistance to acid phagocytosis. This suggests 
that glycans on flagellin surface play a critical role in viru-
lence [13].  
 Studies involving mass spectrometry as a key technique 
lead to the elucidation of all of the components involved in 
the biosynthesis of CMP-pseudaminic acid. These studies 














Fig. (10). The structures of Pseudaminic Acid (13), Legionaminic acid (16) and their discussed derivatives. 
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thetic pathway and that pseG acted as a hydrolase removing 
UDP from one of the sugar intermediates [34, 179, 180] to 
produce the substrate for pseI, which could then produce 
pseudaminic acid (13) [181]. 
Elucidation of the Legionaminic Acid Biosynthetic Path-
way 
 The proposed pathway can be seen in Fig. (9). It pro-
ceeds in two parts, the first part produces the Guanosine 
diphosphate (GDP) sugar and the second produces the final 
CMP-linked legionaminic acid (16).  
 Whilst studying O-linked flagellar glycosylation in Cam-
pylobacter, Logan and co-workers investigated C. coli 
VC167 [182], which lacks a full set of pgl genes but contains 
another set of genes ptmA-F, which they believed were re-
sponsible for the production of pseudaminic acid (13) in this 
organism. Most other Campylobacter have this gene set, 
although not the sub-species C. jejuni 81-76. The homo-
logues in C. jejuni NTC11168 are, ptmC (Cj1327), ptmD 
(Cj1328), ptmE (Cj1329), ptmF (Cj1330), ptmB (Cj1331) 
and ptmA (Cj1332).  
 Comparisons of flagellins from both C. coli VC167 and 
C. jejuni 81-76 showed that both contained the acetamidino 
form of pseudaminic acid (15). However, tandem MS of 
peptides from C. coli identified four carbohydrate modifica-
tions with neutral losses of 316 m/z, 317 m/z, 432 m/z and 
433 m/z. Fragmentation data showed that the profile for the 
317 m/z was consistent with that for pseudaminic acid (13). 
The spectrum for the 316 m/z, whilst expected to be the 
acetamidino form of pseudaminic acid (15), turned out not to 
be as it had a different fragmentation profile and remained 
unidentified. The profiles of both the 432/433 m/z moieties 
showed a loss of 116 m/z, which could be accounted for by 
the addition of a deoxypentose to the 316/317 m/z. Apart 
from the 116 m/z ion the 432 spectrum resembled that for 
the unidentified 316 m/z and the 433 resembled that of the 
317 m/z (pseudaminic acid) (13). Mutations of the ptm genes 
in C. coli VC167 led to tryptic peptides that had previously 
carried the 316 m/z and 432 m/z being replaced with 317 
m/z and 433 m/z and a resultant loss of antigenicity of the C. 
coli flagellin. Thus, there appeared to be two distinct pseu-
daminic acid (13) structures on the flagellin of the two 
strains [182]. 
 Building on previous work, [180] McNally carried out a 
targeted metabolomic analysis of C. coli VC167, using NMR 
in conjunction with top down analysis and HILIC MS on the 
flagellin and its associated tryptic fragments [54]. This work 
lead to the identification of two structurally distinct CMP-
linked carbohydrate derivatives of legionaminic acid 
(Leg5Ac7Ac) (16), an acetamidino (Leg5Am7Ac) (17) and 
N-methylacetimidoyl (Leg5AmNMe7Ac) (18) form, shown 
in Fig. (10). Thus, the previously unidentified 316 m/z was, 
in fact, legionaminic acid (16). Further work with knockout 
mutants identified that the ptm genes were thus responsible 
for the production of legionaminic acid (16) and its CMP-
activated derivatives and that this is a completely separate 
pathway to that for pseudaminic acid (13). McNally also 
identified a further two genes involved in the pathway 
ptmG&H and with his dataset made the first attempt to pre-
dict a full biosynthetic pathway for legionaminic acid [54].  
 However, the entire legionaminic pathway in C. jejuni 
has only recently been elucidated by Schoenhofen et al. 
[183] using a systems biology approach involving bioinfor-
matics, comparative genomics, metabolomics and functional 
assays. This considerable and impressive piece of work has 
identified eleven enzymes involved in the production of 
CMP-activated legionaminic acid. Interestingly unlike the 
di-N-acetyl bacillosamine (8) and pseudaminic (13) path-
ways, this pathway acts through GDP as opposed to UDP 
intermediates; this may provide a mechanism for the path-
ways to stay segregated.  
N-linked Glycosylation: Di-N-Acetyl Bacillosamine Bio-
synthetic Pathway 
 The proposed mechanism for N-linked glycosylation in 
C. jejuni is shown in Fig. (11). 
 Examination of the full genome sequence of C. jejuni 
NCTC 11168 showed that there are effectively two glycosy-
lation loci. The first being the flagellin biosynthesis and 
modification locus containing about 50 genes in the region 
Cj1293-Cj1344 encompassing the gene loci for the pseu-
daminic acid (13) and legionaminic acid (16) biosynthesis 
pathways [168, 169, 174]. 
 The second region from Cj1119-Cj1152 encoded for 
lipo-oligosaccharide and general glycosylation, including 
flagellin. Contained within this region is the pgl/wla gene 
locus Cj1119-Cj1131, which is highly conserved in Campy-
lobacter and does not contain phase variable genes with ho-
mopolymeric sequences [12, 98, 100, 168].  
 When investigating this gene locus Linton et al. [184] 
identified two glycosylated proteins from C. jejuni NCTC 
11168. Lectin capture of the proteins using Soya Bean Ag-
glutinin (SBA) demonstrated that the proteins contained ter-
minal GalNAc (6) residues, treatment with ?-N-
acetylgalactosamidase removed their ability to bind to SBA, 
demonstrating that the terminal GalNAc (6) residues were 
attached via an ?(1?3) linkage. Disruption of the C. jejuni 
NCTC 11168 pgl genes: pglH, pglI, pglJ, pglA, pglD and 
pglE resulted in the loss of binding of these proteins to SBA, 
thus demonstrating that the pgl locus is responsible for the 
observed glycosylation. After lectin capture the glycopro-
teins were separated on an SDS gel, bands were extracted 
digested and subjected to MALDI-TOF analyses with pep-
tide mass fingerprinting and identified as PEB3 (Cj0289c), a 
highly immunogenic protein and a putative periplasmic pro-
tein (Cj1670c). Using computer based predictions Linton et 
al. suggested that the gene products of pglH, pglI, pglJ, 
pglA, and pglC acted as putative glycosyltransferases; pglB, 
wlaJ and pglG were integral membrane proteins; pglD, pglE 
and pglF were involved in sugar biosynthesis; walB encoded 
an ABC transporter and galE, which encodes a UDP-glucose 
4-epimerase (conversion of UDP-glucose to UDP-galactose) 
[166] are all involved in this protein glycosylation process 
[184]. 
 Young et al. [85] carried out an extensive analysis of the 
C. jejuni NCTC 11168 glycoprotein complement identifying 
more than thirty potential glycoproteins. They specifically 
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isolated and analyzed the PEB3 (Cj0289c) protein. MS 
analysis of the PEB3 showed an expected MS peak at 25,454 
Da and an unexplained peak at 26,861 Da. The fraction con-
taining the 26,861 Da peak was tryptically digested and all 
peptides could be assigned to PEB3 bar one. This tryptic 
peptide was identified as DFNVSK and tandem MS con-
firmed that it was a glycopeptide; the mass of the oligosac-
charide was 1406 Da with a fragmentation profile equivalent 
to the loss of 5 x HexNAc (203 Da), a single Hex (162 Da) 
and an unidentified 228 Da moiety. To determine whether 
the oligosaccharide was O-linked, ?-elimination was at-
tempted, however, this failed to remove the oligosaccharide 
from the peptide.  
 Further tandem MS and examination of the b3 +228 ion 
fragment showed that the glycan structure was attached to 
the peptide backbone via the 228 moiety being bound to an 
Asn. This was thus the first instance of an N-linked glycosy-
lation event in C. jejuni, further evidenced by the fact that 
the Asn to which the sugar was attached was within the eu-
karyotic N-linked consensus sequence Asn-X-Ser. Isolation 
of other glycoproteins in this study using SBA revealed a 
number of other N-linked glycoproteins with the same gly-
can structure attachment and linkage to the eukaryotic se-
quon. NMR studies elucidated the heptasaccharide structure 
of the glycan to be GalNAc(6)-?(1?4)-GalNAc(6)-?(1?4)–
[Glc(2)-?-(1?3)]GalNAc(6)-?(1?4)-GalNAc (6)-?(1?4)-
GalNAc (6)-?(1?3)–Bac (8)-?–N-Asn (see Fig. (12)). Bac 
is 2,4-diacetamido-2,4,6-trideoxyglucopyranose, a di-N-
acetyl derivative of bacillosamine (8) an unusual carbohy-
drate specific to certain bacteria [85].  
 Further investigations of this gene set demonstrated that 
pglB has high sequence homology to yeast STT3, which has 
been shown to be an essential subunit of the N-linked oligo-
saccharyltransferase complex. The PglB protein also con-
tains the highly conserved WWDYGY motif, which is found 
in a number of STT3 oligosaccharyltransferase homologues, 
this is located on the hydrophilic C-terminal of the protein 
orientated towards the periplasmic space [185]. Wacker et al. 
[185] demonstrated that the pglB gene product functions as 


















Fig. (11). N-linked glycosylation in C. jejuni: The process is as follows: UDP-Bac is produced by the sequential action of PglF, a dehydra-
tase, PglE, an aminotransferase and PglD, an acetyl transferase, on UDP-GlcNAc. The UDP-Bac is transferred to a lipid carrier, undeca-
prenyl phosphate, attached to the cytoplasmic face of the cell membrane, by the action of PglC. PglA adds the first GalNAc (6) residue to the 
Bac, the next residue is added by PglH, PglJ until all four residues have been added. PglI attaches the glucose (2) residue to the side chain of 
the third GalNAc (6), completing the heptasaccharide chain. PglK flips this entire chain across the inner membrane to the periplasmic space 
where pglB attaches it to the N-glycosylation sites on proteins. UDP Uridine diphosphate, ? UDP-GlcNAc,  
P-                   undecaprenyl phosphate, ? Glucose (2),        GalNAc (6),        diacetyl Bacillosamine (8). 
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linkage of the heptasaccharide sugar to the polypeptide 
backbone of the glycoprotein. Mutants without this gene 
produced proteins without immunoreactivity or the ability to 
bind SBA. When PEB3 was purified from this mutant MS 
analysis showed that it completely lacked the glycan attach-
ment. It was, therefore, postulated that in C. jejuni the hepta-
saccharide is assembled in the cytoplasm on a lipid carrier, 
probably a bactoprenyl pyrophosphate, translocated to the 
periplamic side of the membrane and then transferred to the 
protein by PglB [185]. 
 Mutation of the pgl genes was also shown to have no 
effect on lipo-oligosaccharide or capsular oligosaccharide 
proteins demonstrating that this gene locus is not involved in 
these pathways but in the glycosylation of glycoproteins 
[185].  
 All the proteins identified in this study containing the 
Bac (8) heptasaccharide were classified as periplasmic, sug-
gesting that the periplasmic space may function in a similar 
manner to the endoplasmic reticulum in eukaryotes [185]. In 
fact, all N-linked proteins identified to date contain predicted 
signal peptides and would, therefore, have to transverse the 
periplasmic space to move extracellular [186].  
 This study showed that multiple glycoproteins contain 
the same glycan, demonstrating that several biological func-
tions could be affected by alteration of the pgl gene locus 
[184]. In fact, previous studies on the pgl gene locus had 
already shown it to play a role in immunogenicity, with dele-
tion of genes within this set leading to a reduction in the abil-
ity of C. jejuni to adhere to and invade cells in vitro and to 
colonize the intestinal tract of mice [11, 12]. 
 Further elucidation of the mechanism of N-linked glyco-
sylation was provided by the introduction of the C. jejuni pgl 
locus into E. coli with concomitant knocking out of each of 
the functional genes. The effect of the knock out of each of 
these genes was studied by tandem MS analysis of the glyco-
sylation of PEB3 glycopeptides [187] and provided funda-
mental insights. Inactivation of pglB and galE resulted in 
peptide fragmentation patterns lacking any glycan structures. 
pglB has thus a role in the protein glycosylation reaction, 
presumably as an oligosaccharyl transferase. Given the struc-
ture of the heptasaccharide it is likely that galE produces a 
protein that is involved in the biosynthesis of the GalNAc (6) 
sugars [187]. Inactivation of pglI led to the production of 
glycopeptides with fragmentation patterns consistent with a 
hexasaccharide sequence and when compared to the wild 
type heptasaccharide tandem MS profile was shown to be 
missing a single hexose residue. It, therefore, seems likely 
that pglI encodes a ?(1?3) glucotransferase that links the 
side chain glucose to the glycan chain once the hexasaccha-
ride core has already been formed. 
 Inactivation of pglA resulted in a glycopeptide with a 
tandem MS profile consistent with one Bac residue attached 
to the peptide suggesting that it produces an ?(1?3)-N-
acetylgalactosaminyltransferase, attaching the first GalNAc 
(6) to the Bac (8) sugar. Similarly, inactivation of pglJ led to 
tandem MS fragments consistent with the GalNAc (6)-Bac 
(8) disaccharide being present indicating its role as a 
?(1?4)-N-acetylgalactosaminyltransferase in the addition of 
the second GalNAc (6) to the heptasaccharide glycan. Like-
wise, pglH is responsible for the addition of the third Gal-
NAc (6) and pglJ for the fourth; it is currently unsure how 
the fifth and sixth are added but it could be carried out by 
further additions from pglJ/H.  
 The final putative transferase pglC is thought to be in-
volved in the transfer of the first sugar residue onto a lipid 
carrier (undecaprenyl pyrophosphate), there is some evi-
dence based on its sequence homology to a Salmonella pro-
tein that carries out a similar function. However, direct evi-
dence for its role came from Glover et al., who demonstrated 
that PglC transfers UDP-Bac directly to undecaprenyl phos-
phate lipid to form Und-PP-Bac [188]. GalD, E&F were also 
suggested to be involved in Bac (8) biosynthesis [187]. 
 Studies on the characterization of this pathway in vivo 
were performed by the use of high-resolution magic angle 
spinning nuclear magnetic resonance (HR-MAS NMR), with 
MS analysis being an integral part of the confirmatory proc-
ess for the mechanisms of this pathway. Interestingly, after 
knockout of the wlaB gene, there was a loss of N-linked gly-
can detection in both NMR & MS and also removal of SBA 
reactivity and loss of colonization ability of the C. jejuni. 
This demonstrated that the ABC transporter WlaB (renamed 
pglK) is essential in N-linked glycosylation [189]. 
 A number of studies, using MS as core technology, iden-
tified the enzymatic activities of PglF [177, 178], PglE [167] 
and PglD [92]. The biosynthetic pathway was finally fully 
characterized by Oliver et al. [92]. Astonishingly, this group 
was able to produce the full heptasaccharide in ‘one shot’ by 
mixing the various proteins from the pgl gene loci with co-
factors in two test tubes [92].  
ROLE OF GLYCOSYLATION IN Mycobacterium tuber-
culosis 
 Infections with Mycobacterium tuberculosis (Mtb) cause 
tuberculosis, one of the most widespread and deadliest infec-
tious diseases worldwide. Once thought to be defeated, a 





Fig. (12). The structure of the heptasaccharide chain involved in C. jejuni N-linked glycosylation. ?  Glucose (2),      GalNAc (6), ? diacetyl 
Bacillosamine (8). 
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velopment of multidrug resistant (MDR) and extensively 
drug resistance (XDR) strains and due to HIV co-infection 
[190]. Although tuberculosis primarily attacks the lungs, 
other organs such as the central nervous system, the gastroin-
testinal system etc. can also be affected [191]. A number of 
surface proteins of Mtb are involved in cell-cell recognition 
and thus mediate immunological responses [192-194].  
 Particularly, host-pathogen interactions of mycobacterial 
surface molecules with the mannose receptor (MR) on the 
host’s macrophages [195-198], the dendritic cell-specific 
ICAM-3 grabbing nonintegrin (DC-SIGN) on dendritic cells 
and monocyte-derived macrophages [199, 200] and Dectin-1 
on macrophages [201] have been documented. Evidently, 
carbohydrates play a pivotal role in these interactions and 
thus in the mycobacterial infestation of the hosts. Since Mtb 
is phagocytosed but not digested, mycobacterial intracellular 
survival seems to be dependent on the bacterium’s strategy 
to escape immune responses in macrophages. 
 Next to the abundant cell wall lipoglycans (lipoarabino-
mannans (LAMs), lipomannans (LMs) and phosphatidyli-
nositol mannosides (PIMs)) glycoproteins emerge as viru-
lence factors. In fact, glycosylated Mtb proteins were already 
pursued in the 80s for their antigeneic properties [202, 203]. 
However, until the 90s, most glycoproteins in Mtb were 
identified solely on their ability to bind the lectin ConA 
[204-205]. In these initial studies, a 19kDa glycoprotein 
[205], a 45/47 glycoprotein [206] and a 38 KDa and 50/55 
kDa glycoprotein [204] were detected. The 45/47 glycopro-
tein is homologous to 50/55 kDa glycoprotein [206]. Due to 
the ubiquitous presence of cell wall lipoglycans (LAMs, 
LMs and PIMs) that may easily contaminate proteins and 
thus lead to false positive glycoprotein identifications, a real 
breakthrough was achieved, when glycosyl units were found 
to be covalently bound to peptides by MS [207]. Four 
threonine residues in 45/47 kDa glycoprotein Apa (Rv1860) 
were found to be linked to mannose (3), mannobiose and 
manotriose [207]. Horn showed later that, in fact, up to 9 
mannose residues can be attached to the threonines of Apa 
[208].  
 Through site-directed mutagenesis and ConA binding, 
two threonines were shown to be glycosylated in the 19 kDa 
antigen LpqH lipoprotein and this glycosylation protected 
the proteins from proteolysis [209]. Our MS data suggest 
further glycosylation sites in this region (Bell et al. unpub-
lished results). LpqH has been described as adhesin, binding 
to mannose receptors and thus inducing phagocytosis of 
monocytic cells [195]. In macrophages, LpqH induces a 
TLR-2 dependent bactericidal response [210], but at the 
same time cytokine production [211] antigen-processing and 
MHC II expression is reduced [211-213], thus successfully 
evading the immune response of its host. The B-cell antigen 
Superoxide dismutase C, SodC (Rv0432), is another putative 
lipoprotein that was recently shown to be glycosylated by 
MS. Of the six glycosylation sites, three were found at 
threonines (T 45, T46 and T51) and three were found at seri-
nes (S48, S53 and S58) [214].  
 Secreted glycosylated and nonglycosylated proteins of 
Mtb were also characterized in a top-down fashion using 
ECD after ConA column enrichment of cell culture filtrate 
[215]. Of the 689 components that were characterized by 
mass spectrometry, ten proteins were further characterized. 
Consecutive losses of 162 Da indicative of hexoses were 
shown for a fragment of the ESAT-6 like protein esxB (CFP-
10) and other unnamed proteins [215]. Together with ESAT-
6, CFP-10 forms a heterodimer that induces a strong T-cell 
mediated immune response [216]. The role that glycosyla-
tion plays in this process has not yet been explored.  
 Espitia et al. [204] were the first to use bottom-up glyco-
proteomics to globally characterize glycoproteins in cell cul-
ture filtrates [217]. Using ConA lectin affinity capture, fol-
lowed by 2D-GE combined with LC-MS/MS, 41 putative 
mannosylated proteins were identified, with many belonging 
to the putative lipoproteins Lpp. While a number of predic-
tion tools such as SignalP predictions (http://www.-
cbs.dtu.dk/services/SignalP), NetOglyc predictions (http://-
www.cbs.dtu.dk/services/NetOGlyc) and LipoP algorithms 
(http://www.cbs.dtu.dk/services/LipoP) were used in this 
study, no attempt was made to characterize individual glyco-
sylation sites by MS.  
 All of the glycoproteins characterized in Mtb so far are 
O-glycosylation with mannose as the most prominent sugar. 
It is generally believed that Mtb does not have N-
glycosylated proteins since it is lacking the analogon to 
PglA. Mtb, however, possesses a homolog to PglB, namely 
Rv1505c, a currently uncharacterized protein [218]. PglB is 
the protein that attaches the activated sugar to the consensus 
protein sequence site in the periplasm. It may therefore be 
hypothesized that the homolog Rv1505c could have the same 
function in Mtb. In addition, there is also a homolog to PglE, 
namely Rv1504c [218]. In both, Neisseria sp. and Mtb, the 
genes for these proteins are located adjacent to each other on 
Chromosome 1. Whether or not N-glycosylated proteins ex-
ist in Mtb remains to be determined.  
CONCLUSIONS 
 Much progress has been made when comparing the ear-
lier dogma that only eukaryotes possess glycoproteins to the 
plethora of O- and N-glycosylated proteins now known to 
exist in prokaryotes. Due to the advances in MS technology 
in terms of ionization efficiency and sensitivity, MS has of-
ten been an enabling part showing definite proof of glycosy-
lation on the molecular level. At the same time, more re-
search is necessary to elucidate the synthesis, structure and 
complex interactions of bacterial glycoproteins with host 
cells. A better understanding of their role in host-pathogen 
interactions will ultimately lead to better cures.  
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ABBREVIATIONS 
ESI-MS = Electrospray Ionization Mass Spectrome- 
try 
MALDI- MS = Matrix-Assisted Laser Desorption Ioniza- 
tion Mass Spectrometry 
HPLC = High Performance Liquid Chromatogra 
phy 
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CID = Collisional Induced Dissociation 
CAD = Collisional Activated Dissociation 
IRMPD = Infrared Multiphoton Dissociation 
ECD = Electron Capture Dissociation 
ETD = Electron Transfer Dissociation 
GlcNAc = N-Acetyl Glucosamine 
GalNAc = N-Acetyl-Galactosamine 
ConA = Concanavalin A 
WGA = Wheat Germ Agglutinin 
GCC = Graphite Carbon Chromatography Col- 
umns 
HILIC = Hydrophilic Interaction Chromatography 
RP = Reversed Phase  
PNGase F = Peptide-N-Glycosidase-F 
NaBH4 = Sodium Borohydride 
NaBH3CN = Cyanoborohydride 
Neu5Ac = N-Acetyl Neuraminic Acid 
CMP = Cytidine Monophosphate 
Pse5Ac7Ac = Pseudaminic Acid 
Pse5Am7Ac = 5-Acetamidino-7-Acetamido-Pseudaminic 
Acid 
Pse5Pr7Pr = N-2,3-Dihyrdroxypropionyl Pseudaminic  
Acid 
UDP = Uridine Diphosphate 
AltNAc = N-Acetyl-Altrosamine 
GDP = Guanosine Diphosphate 
Leg5Ac7Ac = Legionaminic Acid 
Leg5Am7Ac = Acetamidino Derivative of Legionaminic 
Acid 
Leg5Am- = N-Methylacetimidoyl Derivative of Leg-  
NMe7Ac  ionaminic Acid 
Bac = Di-N-Acetyl Bacillosamine 
SDS = Sodium Dodecyl Sulphate 
Und-PP = Undecaprenyl Pyrophosphate 
HR-MAS NMR = High-Resolution Magic Angle Spinning  
nuclear Magnetic Resonance 
SBA = Soyabean Agglutinin 
MDR = Multidrug Resistant 
LAMs = Lipoarabinomannans 
LMs = Lipomannans 
PIMs = Phosphatidylinositol Mannosides 
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